Sharon Bio-Medicine Ltd. announced earnings results for the fourth quarter ended March 31, 2021. For the year, the company announced total revenue was INR 1,769.674 million compared to INR 1,730.014 million a year ago. Net income was INR 140.466 million compared to net loss of INR 564.664 million a year ago. Basic earnings per share from continuing operations was INR 24.41 compared to INR 1.42 a year ago. For the quarter, total revenue was INR 506.475 million compared to INR 462.863 million a year ago. Net income was INR 56.097 million compared to INR 60.251 million a year ago. Basic earnings per share from continuing operations was INR 9.75 compared to INR 0.51 a year ago.